Cargando…

Cytochrome P450 modulates the therapeutic actions of tamoxifen, as evidenced in novel breast cancer models

Detalles Bibliográficos
Autores principales:	Polson, E, Weidlich, S, Stenhouse, A, Friedberg, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300753/ http://dx.doi.org/10.1186/bcr1934

Ejemplares similares

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy
por: Friedberg, T, et al.
Publicado: (2006)

Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy
por: Thota, Kanakaiah, et al.
Publicado: (2018)

Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues.
por: Friedberg, T, et al.
Publicado: (1990)

Functional characterisation of cytochrome P450s involved in insecticide resistance in major malaria vector Anopheles funestus across Africa
por: Wondji, Charles, et al.
Publicado: (2014)

Role of p27 in tamoxifen response in breast cancer cell lines
por: Nilsson, S, et al.
Publicado: (2009)

Pandemic triage: clipboard medicine or evidenced based?
por: Guest, T, et al.
Publicado: (2009)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain
por: Burris-Hiday, Sarah D., et al.
Publicado: (2023)

Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People
por: Khan, Burhan A., et al.
Publicado: (2018)

Efficacy of implementation strategies of an evidenced-based awakening and breathing protocol
por: Almuslim, O, et al.
Publicado: (2011)

RV dyssynchrony in PAH as evidenced by slice to slice minimum volume timing
por: Han, Qiao, et al.
Publicado: (2015)

Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
por: Bezerra, Lucas Soares, et al.
Publicado: (2018)

Expression of cytochrome P450IA in breast cancer.
por: Murray, G. I., et al.
Publicado: (1991)

Cytochrome P450: Implications for human breast cancer
por: Luo, Bin, et al.
Publicado: (2021)

The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009)

Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018)

Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450
por: Brewer, Christopher Trent, et al.
Publicado: (2017)

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics
por: Pang, Hui, et al.
Publicado: (2021)

The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

Fungal cytochrome P450 database
por: Park, Jongsun, et al.
Publicado: (2008)

Cytochrome P450 humanised mice
por: Gonzalez, Frank J
Publicado: (2004)

Intronic polymorphisms of cytochromes P450
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2010)

The Role of Cytochromes P450 in Infection
por: Stavropoulou, Elisavet, et al.
Publicado: (2018)

Cytochromes P450, Oxygen, and Evolution
por: Lewis, David F.V., et al.
Publicado: (2001)

Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver
por: Zhang, Hai-Feng, et al.
Publicado: (2016)

1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology
por: de Montellano, Paul R Ortiz
Publicado: (2018)

Stick or switch? Audit of the use of switch therapy from tamoxifen to an aromatase inhibitor in breast cancer
por: Weeraman, S, et al.
Publicado: (2010)

Fungal Cytochrome P450s and the P450 Complement (CYPome) of Fusarium graminearum
por: Shin, Jiyoung, et al.
Publicado: (2018)

Cytochrome P450-Mediated Phytoremediation using Transgenic Plants: A Need for Engineered Cytochrome P450 Enzymes
por: Kumar, Santosh, et al.
Publicado: (2012)

Streptomyces Cytochrome P450 Enzymes and Their Roles in the Biosynthesis of Macrolide Therapeutic Agents
por: Cho, Myung-A, et al.
Publicado: (2019)

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
por: Thompson, AM, et al.
Publicado: (2010)

Role of cytochrome P450 in drug interactions
por: Bibi, Zakia
Publicado: (2008)

The planetary biology of cytochrome P450 aromatases
por: Gaucher, Eric A, et al.
Publicado: (2004)

The cytochromes P450 and mechanisms of chemical carcinogenesis.
por: Parke, D V
Publicado: (1994)

Cytochromes P450: a success story
por: Werck-Reichhart, Danièle, et al.
Publicado: (2000)

Basic Review of the Cytochrome P450 System
por: McDonnell, Anne M, et al.
Publicado: (2013)

The cytochrome P450 (CYP) superfamily in cnidarians
por: Pankov, Kirill V., et al.
Publicado: (2021)

Inter-ethnic differences in efavirenz CNS toxicity – role of cytochrome P450 2B6 polymorphisms
por: Lee, Lawrence S, et al.
Publicado: (2012)

RV work efficiency is greatly reduced in patients with pulmonary arterial hypertension as evidenced by 4D flow cardiac MRI
por: Han, Qiao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_60saitpbmf0tf3vtebgb0721db